Browse result page of B3Pdb

The total number entries retrieved from this search are 92, scroll left/right for detailed information.
B3pdbIDPEPTIDE NAMEPEPTIDE SEQUENCE (1-letter)PEPTIDE SEQUENCE (3-letter)N-TERMINAL MODIFICATIONC-TERMINAL MODIFICATION CHEMICAL MODIFICATIONPEPTIDE LENGTHPEPTIDE CONFORMATIONPEPTIDE NATURESOURCE/ORIGIN OF PEPTIDESMILESCELL LINEIn vitro CONCENTRATIONIn vitro METHODIn vitro RESULTANIMAL MODELIn vivo CONCENTRATIONIn vivo MODE OF DELIVERYIn vivo METHODIn vivo RESULTACTIONTRANSPORT TYPESUBCELLULAR LOCALISATIONCOMBINATIONPHYSICAL CONDITIONRESPONSERESULTLABELPMID
b3pdb_0259NeurotensinELYENKPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OHNANANA13TridecapeptideNAbovine hypothalamusN[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)ONANAAdult male Swiss-Webster miceNAStudent's t-test (two-tailed) and Mann-Whitney U-testNANANANA Not able to cross the BBB in sufficient quantities to exert direct brain effects. Can modify the sed NA NA NA NA NA NA NA 406965
b3pdb_0332TatYGRKKRRQRRRTyrGlyArgLysLysArgArgGlnArgArgArgNANANA11LinearNANANANANANANANANANANANA NA NA NA NA NA NA NA NA 28442909
b3pdb_0340TATYGRKKRRQRRRNANANANA11LinearNANANANANANANANANANANANA NA NA NA NA NA NA NA NA 28699828
b3pdb_0346Phoenixin-14DVQPPGLKVWSDPF-amideAspValGlnProProGlyLeuLysValTrpSerAspProPhe-amideNANANA14LinearNANANANANAMale Wistar ratsNANANANANANA NA NA NA NA NA NA NA NA 28965207
b3pdb_0347CTPYGRRARRRRRRTyrGlyArgArgAlaArgArgArgArgArgArgNANANA11LinearNANANANANANANANANANANANA NA NA NA NA NA NA NA NA 28971613
b3pdb_0367α-MSHAc-SYSMEHFRWGKPV-NH2Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2NANANA13LinearNANANANANANANANANANANANA NA NA NA NA NA NA NA NA 23294313
b3pdb_040311 poly-arginineRRRRRRRRRRRArgArgArgArgArgArgArgArgArgArgArgNANANA11LinearNANANANANAmiceNANANANANAhighly regulated CPP-dependent manner NA NA NA NA NA NA NA NA 25081308
b3pdb_0414Somatostatin-14AGCKNFFWKTFTSCAla-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-CysNANACys3-Cys1414LinearNAhuman,bovine,mouse,ratO=C1NC(C(=O)NC(C(=O)O)CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC1C(O)C)Cc2ccccc2)C(O)C)CCCCN)Cc4c3ccccc3nc4)Cc5ccccc5)Cc6ccccc6)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(N)C)CONANANANANANANANANA NA NA NA NA NA NA NA NA NA
b3pdb_0675α Melanocyte stimulaAc-SYSMEHFRWGKPVAc-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-ValNANANA13LinearNAmouse,ratO=C(N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)O)C(C)C)CCC1)CCCCN)Cc3c2ccccc2nc3)CCCNC(=[N@H])N)Cc4ccccc4)Cc5ncnc5)CCC(=O)O)CCSC)CO)[C@@H](NC(=O)[C@H](NC(=O)C)CO)Cc6ccc(O)cc6NANANANANANAIntracarotid injectionNANA NA Permeability NA NA NA Blood/brain ratio 108 Direct iodination 2413968
b3pdb_0677JMV 2012KKPYILKKPYILLys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-LeuNANANA12LinearNAhuman,mouse,ratO=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCNNANANANANANAin situ brain perfusionNANA NA saturable NA NA NA Unidirectional flux rate constant 0.00339 mL/(g x min) Direct iodination 8786534
b3pdb_0678JMV 2012KKPYILKKPYILLys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-LeuNANANA12LinearNAhuman,mouse,ratO=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCNNANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Initial distribution vaolume 0.0267 ml/g Direct iodination 8786534
b3pdb_0679JMV 2012KKPYILKKPYILLys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-LeuNANANA12LinearNAhuman,mouse,ratO=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCNNANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA permiability constant 0.000000565 cm/s Direct iodination 8786534
b3pdb_0680JMV 2012KKPYILKKPYILLys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-LeuNANANA12LinearNAhuman,mouse,ratO=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCNNANABMECNANANANANANA NA saturable NA NA NA Permeability coefficient 0.000153333 cm/s NA 8371162, 8786534
b3pdb_0705Dynorphin (1-13)YGGFLRRIRPKLKTyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-LysNANANA13LinearNAChemically synthesizedO=C(NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CCCCN)CC(C)C)CCCCN)CCC1)CCCNC(=[N@H])N)C(C)CC)CCCNC(=[N@H])N)CCCNC(=[N@H])N)CC(C)C)Cc2ccccc2)CNC(=O)C(N)Cc3ccc(O)cc3NANABUI methodNANANANANANA NA NA NA NA NA BUI 0.14% H3/C14 9639252
b3pdb_0735(D)Trp11-NeurotensinPyr-LYENKPRRPwILPyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-(D)Trp-Ile-LeuNANANA13LinearNAChemically synthesizedO=C(O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC(C)C)Cc2ccc(O)cc2)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N3CCC[C@@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N6[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)O)[C@H](C)CC)[C@@H](C)CC)Cc5c4ccccc4nc5)CCC6)CCCNC(=[N@H])N)CCCNC(=[N@H])N)CCCCN)CC(=O)NNANANANANANANANANA NA NA NA NA NA NA NA NA NA
b3pdb_0743Substance PRPKPQQFFGLM-NH2Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2NANANA11LinearNAChemically synthesizedO=C(N)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2N(C(=O)C(NC(=O)C1N(C(=O)C(N)CCCNC(=[N@H])N)CCC1)CCCCN)CCC2)CCC(=O)N)CCC(=O)N)Cc3ccccc3)Cc4ccccc4)CC(C)C)CCSCNANANANANANAIntracarotid injectionNANA NA Permeability NA NA NA Blood/brain ratio 258 Direct iodination 2413968
b3pdb_0975Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.05 min-1 Direct iodination 26465925
b3pdb_0976Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANAShake FlaskNANANANANANA NA NA NA NA NA % capillary 23.05% Direct iodination 26465925
b3pdb_0977Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANAShake FlaskNANANANANANA NA NA NA NA NA % parenchyma 76.95% Direct iodination 26465925
b3pdb_0978Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00563 mL/(g x min) Direct iodination 26465925
b3pdb_0979Tat 47-57YGRKKRRQRRR-NH2Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2NANANA11LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.02762 ml/g Direct iodination 26465925
b3pdb_1095THRPPMWSPVWP-NH2THRPPMWSPVWP-NH2Thr-His-Arg-Pro-Pro-Met-Trp-Ser-Pro-Val-Trp-Pro-NH2NANANA12LinearNAChemically synthesizedN[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(CO)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N1[C@@]([H])(CCC1)C(=O)ONANAInitial concentration in donor chamber-CultureNANANANANANA NA Saturable NA NA NA Parallel artificial membrane permeation assay apparent permiability cofficient 0.0000125 cm/s NA 25650865
b3pdb_1096T(NMe)H(NMe)RPPM(NMeT(NMe)H(NMe)RPPM(NMe)WSPVWP-NH2Thr-(NMe)-His-(NMe)-Arg-Pro-Pro-Met-(NMe)-Trp-Ser-Pro-Val-Trp-Pro-NH2NANANA12LinearNAChemically synthesizedNANANAInitial concentration in donor chamber-CultureNANANANANANA NA Saturable NA NA NA Parallel artificial membrane permeation assay apparent permiability cofficient 0.0000099 cm/s NA 25650865
b3pdb_1097THRPPMWSPVWP-NH2THRPPMWSPVWP-NH2(D)Thr-(D)His-(D)Arg-(D)Pro-(D)Pro-(D)Met-(D)Trp-(D)Ser-(D)Pro-(D)Val-(D)Trp-(D)Pro-NH2NANANA12LinearNAChemically synthesizedN[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(CO)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N1[C@@]([H])(CCC1)C(=O)ONANAInitial concentration in donor chamber-CultureNANANANANANA NA Saturable NA NA NA Parallel artificial membrane permeation assay apparent permiability cofficient 0.0000145 cm/s NA 25650865
b3pdb_1098PWVPSWMPPRHT-NH2PWVPSWMPPRHT-NH2(D)Pro-(D)Trp-(D)Val)-(D)Pro-(D)Ser-(D)Trp-(D)Met-(D)Pro-(D)Pro-(D)Arg-(D)His-(D)Thr-NH2NANANA12LinearNAChemically synthesizedN1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(C(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)N[C@@]([H])(CCSC)C(=O)N1[C@@]([H])(CCC1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)ONANAInitial concentration in donor chamber-CultureNANANANANANA NA Saturable NA NA NA Parallel artificial membrane permeation assay apparent permiability cofficient 0.0000214 cm/s NA 25650865
b3pdb_1125NeurotensinELYENLPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-LeuNANANA13LinearNAbacterialNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.053 min-1 Direct iodination 27040796
b3pdb_1126NeurotensinELYENLPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-LeuNANANA13LinearNAbacterialNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 88.87% Direct iodination 27040796
b3pdb_1127NeurotensinELYENLPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-LeuNANANA13LinearNAbacterialNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 11.22% Direct iodination 27040796
b3pdb_1128NeurotensinELYENLPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-LeuNANANA13LinearNAbacterialNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.03383 ml/g Direct iodination 27040796
b3pdb_1129NeurotensinELYENLPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-LeuNANANA13LinearNAbacterialNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00075 mL/(g x min) Direct iodination 27040796
b3pdb_1130NeurotensinELYENLPRRPYILpGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-LeuNANANA13LinearNAbacterialNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.01125 ml/g Direct iodination 27040796
b3pdb_1146D1QSHYRHISPAQVD-Gln-D-Ser-D-His-D-Tyr-D-Arg-D-His-D-Ile-D-Ser-D-Pro-D-Ala-D-Gln-D-ValNANANA12LinearNAChemically synthesizedN[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CO)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(C(C)C)C(=O)ONANAInitial concentration in donor chamber-CultureNANANANANANA NA non saturable NA NA NA Permeability index 3.8 (x 10-4) cm/min NA 19954305
b3pdb_1147D3RPRTRLHTHRNRD-Arg-D-Pro-D-Arg-D-Thr-D-Arg-D-Leu-D-His-D-Thr-D-His-D-Arg-D-Asn-D-ArgNANANA12LinearNAChemically synthesizedN[C@@]([H])(CCCNC(=N)N)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)ONANAInitial concentration in donor chamber-CultureNANANANANANA NA Saturable NA NA NA Permeability index 9.5 (x 10-4) cm/min NA 19954305
b3pdb_1148D3RPRTRLHTHRNRD-Arg-D-Pro-D-Arg-D-Thr-D-Arg-D-Leu-D-His-D-Thr-D-His-D-Arg-D-Asn-D-ArgNANANA12LinearNAChemically synthesizedNANANANANANANANANANA NA Permeability NA NA NA % injected dose 0.14 %/g H3/C14 27423267
b3pdb_1149D3RPRTRLHTHRNRD-Arg-D-Pro-D-Arg-D-Thr-D-Arg-D-Leu-D-His-D-Thr-D-His-D-Arg-D-Asn-D-ArgNANANA12LinearNAChemically synthesizedNANANANANANANANANANA NA Permeability NA NA NA Brain to plasma ratio 0.8 H3/C14 27423267
b3pdb_1157PepH2KLFMALVAFLRFLTLysLeuPheMetAlaLeuValAlaPheLeuArgPheLeuThrNANANA14LinearNAfungalNANANAInitial concentration in donor chamber-CultureNANANANANANA NA Permeability NA NA NA Translocated 9.32% 99mTc(CO)3+ 28263555
b3pdb_1197ANK6RKRIRLVTKKKRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-ArgNANANA12LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Peak response 0.3 µL/(g x min) H3/C14 29966196
b3pdb_1198ANK6RKRIRLVTKKKRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-ArgNANANA12LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.0003 mL/(g x min) H3/C14 29966196
b3pdb_1199ANK6RKRIRLVTKKKRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-ArgNANANA12LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.0575 ml/g H3/C14 29966196
b3pdb_1203cANK6rRKRIRLVTKKKRRArg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-ArgNANANA13LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Peak response 0.3 µL/(g x min) H3/C14 29966196
b3pdb_1210PHT-TGN-HBcTGNYKALHPHNGNANANANA12LinearNAChemically synthesizedNAHuman astrocytes HA18000.2 mg PHT/kgConfocal MicroscopyNAMice0.2 mg PHT/kgIntravenous VIS Lumina II Spectrum Imaging SystemIt demonstrated high penetration ability PHT-TGN-HBc NCs showed high antiepileptic effects in epilepsy mouse model with no side effects Permeability Cerebral vasculature Comined with phenytoin and hepatitis B core Refractory Epilepsy It prolongs the circulation time of the drug and efficiently load large amount of drugs, and showed It efficiently target the brain tissue by 2.4 fold and increase the antiepileptic efficiency of phen NA 32087458
b3pdb_1220CL peptideRLLRLLRRRRRRRRNANANANA14LinearCationicChemically synthesizedNAMDCKII cellsNAConfocal microscopyCL peptide, significantly enhanced the delivery of small-molecule cargo across confluent cell monolaNANANANANA It plays a synergistic role in the transcellular cargo delivery Permeability NA Combined with linker NA NA NA NA 32474121